Bengaluru, India – March 24, 2026 – Leading venture capital firm Accel and global consumer internet group Prosus have announced the selection of six pioneering startups for their first joint cohort in India. This landmark initiative is designed to support what the firms describe as "off-the-map" ideas – ventures tackling problems in nascent or undefined markets, where conventional metrics for progress are often elusive and development timelines are inherently extended. The chosen startups represent a diverse spectrum of science-led themes, including healthcare, climate technology, space exploration, and longevity, areas characterized by long research and development cycles and uncertain commercial pathways. The rigorous selection process saw these six companies emerge from a formidable pool of over 2,000 applications, underscoring the significant demand and burgeoning potential within India’s deep-tech and frontier innovation landscape.
This collaboration between Accel, a seasoned early-stage investor with a long history of backing successful tech companies globally and in India, and Prosus, a major strategic investor with deep pockets and a focus on long-term value creation in emerging markets, marks a pivotal moment for the Indian startup ecosystem. Their joint program specifically targets ventures that operate outside the traditional, fast-growth playbook, recognizing that truly transformative innovations often require a different kind of support – one that prioritizes patient capital, strategic guidance, and a tolerance for non-linear development.
The Genesis of a Unique Partnership and Vision
The partnership between Accel and Prosus was first unveiled in October 2025, with a clear mandate to identify and nurture Indian startups building solutions for the nation’s massive 1.4 billion-strong population. The core philosophy behind this alliance was to move beyond easily fundable, often incremental, innovations and instead focus on foundational technologies and scientific breakthroughs that could address grand challenges. Both firms acknowledged a significant funding gap for deep-tech, science-led, and hardware-intensive startups in India, which often struggle to fit into conventional venture capital models that demand rapid user acquisition or immediate revenue generation.
Accel, with its extensive network and expertise in early-stage investments, brings a deep understanding of the startup journey, from ideation to scaling. Its portfolio includes some of India’s most prominent unicorns. Prosus, on the other hand, a global investment powerhouse with roots in Naspers, offers substantial capital reserves and a long-term investment horizon, having successfully built and scaled businesses across various internet sectors worldwide. This synergistic combination provides the cohort companies with not just financial backing, but also unparalleled strategic mentorship, access to global networks, and operational guidance crucial for navigating complex, uncharted territories. The timing of this initiative aligns with a global trend of increasing investor interest in deep technology, recognizing its potential to drive significant societal and economic impact, even if returns materialize over a longer horizon.
A New Model for Early-Stage Funding: Deferred Equity and Patient Capital
A distinctive feature of this program is its innovative funding structure, meticulously designed to reduce early dilution for founders. Accel and Prosus are co-investing in each selected startup, with Prosus matching Accel’s commitment. The investment checks range from $500,000 to $2 million, providing substantial seed capital for these early-stage ventures. Crucially, a portion of this capital is structured with deferred equity, meaning founders give up a smaller percentage of their company at the initial stage, with additional equity vesting at later milestones or funding rounds.
This deferred equity model is a radical departure from standard venture financing, which often sees founders dilute significant ownership early on to secure necessary capital. For science-led startups, which typically face longer development cycles and higher upfront R&D costs before achieving market readiness, traditional dilution can be particularly penalizing. "More than capital, they require time to make those breakthroughs," explained Pratik Agarwal, a partner at Accel, emphasizing the program’s commitment to providing patient capital. This approach allows founders to retain greater control and focus on their core scientific and technological development without the immediate pressure of demonstrating rapid commercial scalability. It acknowledges that breakthroughs in areas like biotechnology, quantum computing, or advanced materials often follow non-linear paths, where progress is measured by technical milestones rather than conventional business growth metrics.
Ashutosh Sharma, Head of India Ecosystem at Prosus, further elaborated on this unique trajectory, stating that "these companies often follow a non-linear path. Progress depends on achieving key technical breakthroughs rather than steady growth." This understanding underpins the entire program, recognizing that true innovation in these frontier sectors cannot be shoehorned into typical startup growth curves. The emphasis is on fundamental discovery and problem-solving, with commercial viability being a longer-term outcome. This model could potentially set a new standard for funding deep-tech ventures, not just in India but globally, encouraging more investors to adopt a patient and founder-friendly approach.
The Inaugural Cohort: Pioneering Solutions Across Critical Sectors
While the specific names of the six startups in the inaugural cohort have not yet been publicly disclosed, the firms have revealed the thematic areas they span: healthcare, climate, space, and longevity. These sectors are at the forefront of global innovation and address some of humanity’s most pressing challenges.
- Healthcare: Innovations in this domain could range from advanced diagnostics and personalized medicine to novel therapeutics and affordable healthcare delivery models, leveraging AI, biotech, and data science to transform patient outcomes in a country with immense healthcare needs.
- Climate Technology: With India facing significant environmental challenges and committing to ambitious climate goals, startups in this area are likely working on solutions for renewable energy, carbon capture, sustainable agriculture, waste management, or water conservation, contributing to a greener future.
- Space: India’s burgeoning private space sector, supported by recent policy reforms, presents opportunities for startups developing satellite technology, space debris solutions, advanced propulsion systems, or applications leveraging satellite data for earth observation and communication.
- Longevity: This emerging field focuses on extending healthy human lifespan, encompassing research into age-related diseases, regenerative medicine, bio-enhancement, and preventive health technologies, tapping into a global demographic shift towards an aging population.
The selection of these specific areas reflects a strategic choice to invest in fundamental research and development that could lead to paradigm-shifting technologies. These are not incremental improvements but often involve years of scientific experimentation, rigorous testing, and significant capital expenditure before reaching market readiness. The sheer volume of applications – over 2,000 – for this specialized program highlights a robust and eager ecosystem of deep-tech innovators in India, many of whom previously struggled to find suitable funding and mentorship. This program aims to bridge that critical gap, providing a lifeline for ideas that might otherwise remain confined to laboratories or fail to secure the necessary backing to mature.
India’s Evolving Deep-Tech Landscape and Global Context
India’s startup ecosystem has long been celebrated for its rapid adoption of digital technologies, particularly in e-commerce, fintech, and software-as-a-service (SaaS). However, the deep-tech sector, encompassing fields like AI, advanced materials, biotechnology, quantum computing, and space technology, has historically received less venture capital attention compared to its counterparts in Silicon Valley, Europe, or China. This disparity was largely due to the longer gestation periods, higher capital intensity, and greater perceived risk associated with deep-tech ventures.
In recent years, however, there has been a noticeable shift. Government initiatives like "Make in India" and policies promoting research and development have created a more conducive environment for deep-tech. The increasing pool of highly skilled scientific and engineering talent, coupled with growing domestic demand for advanced solutions in sectors like healthcare and climate, has further fueled this growth. Global investors are also increasingly looking beyond easily scalable software models, recognizing the profound impact and potentially higher long-term returns offered by foundational technologies.
The Accel-Prosus initiative is not merely a funding program; it is a catalyst for this evolving landscape. By validating and supporting "off-the-map" ideas, it sends a powerful signal to other investors and aspiring entrepreneurs that India is fertile ground for scientific and technological breakthroughs. It encourages a shift in mindset, moving beyond mere imitation to fostering original research and innovation that can solve global problems. According to industry reports, while overall VC funding in India saw some fluctuations, investments in deep-tech have shown resilience, indicating a growing maturity and diversification of the market. Programs like this are crucial in accelerating this trend, providing the necessary infrastructure and capital for India to become a global hub for frontier technologies.
Implications for India’s Startup Ecosystem and Beyond
The launch of this joint cohort carries significant implications for India’s startup ecosystem, fostering a culture of long-term innovation and risk-taking.
- Validation of Deep-Tech: By focusing on science-led themes and "off-the-map" ideas, Accel and Prosus are lending significant credibility and visibility to a sector that has historically been underserved. This could encourage more entrepreneurs to venture into deep-tech and more investors to consider these opportunities.
- Pioneering a New Funding Model: The deferred equity structure is a game-changer for founders in capital-intensive, long-gestation sectors. It offers a more founder-friendly approach, reducing early dilution and allowing innovators to focus on R&D without immediate pressure for commercialization. If successful, this model could be emulated by other venture funds.
- Cultivating Patient Capital: The program champions the concept of patient capital, which is critical for scientific breakthroughs. It acknowledges that not all innovations can deliver immediate returns, and some require sustained investment over many years. This could help shift the broader VC mindset in India towards a more long-term view.
- Addressing Grand Challenges: By backing startups in healthcare, climate, space, and longevity, the initiative directly contributes to solving some of the world’s most pressing issues. These are not just commercial ventures but often carry significant societal impact potential.
- Global Competitiveness: Fostering indigenous deep-tech capabilities enhances India’s position on the global stage as a hub for advanced research and innovation. It can attract more global talent and investment, further strengthening the ecosystem.
- Ecosystem Maturation: The program contributes to the overall maturation of the Indian startup ecosystem, demonstrating that it can support not just scalable software businesses but also complex, science-driven enterprises. It creates a more diverse and resilient entrepreneurial landscape.
The success of this inaugural cohort will be closely watched, as it could serve as a blueprint for future deep-tech investment models in India and other emerging markets. The commitment of established players like Accel and Prosus to back these high-risk, high-reward ventures signals a growing confidence in India’s ability to produce world-class scientific and technological innovations.
Looking Ahead: The Future of Frontier Tech in India
The Accel-Prosus program is more than just an investment vehicle; it is an incubator for future industries. The chosen startups, operating at the very edge of technological possibility, are tasked with building solutions that could redefine markets and create entirely new ones. The support from two powerhouses like Accel and Prosus provides them with not only financial runway but also strategic depth, mentorship, and access to a vast network, significantly increasing their chances of success in a challenging domain.
As India continues its trajectory towards becoming a major global economic and technological power, initiatives like this are fundamental. They underscore the importance of investing in foundational research and bold ideas, even when their commercial pathways are initially unclear. The future of India’s innovation economy will increasingly depend on its ability to nurture such "off-the-map" ventures, transforming scientific breakthroughs into tangible solutions that benefit billions and propel the nation onto the global stage as a leader in frontier technologies. The inaugural cohort of Accel and Prosus represents a beacon of this ambition, lighting the way for a new era of deep-tech innovation in India.
About the Author
